Connect with us

TechCrunch

FindAir is a smart inhaler

FindAir is digitizing asthma therapy with smart inhaler technology. The TC Top Picks program showcases outstanding early-stage startups across these categories: AI/Machine Learning, Biotech/Healthtech, Blockchain, Fintech, Mobility, Privacy/Security, Retail/E-commerce, Robotics/IoT/Hardware, SaaS and Social Impact & Education. TechCrunch is a leading technology media property, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech…

Published

on

FindAir is digitizing asthma therapy with smart inhaler technology.

The TC Top Picks program showcases outstanding early-stage startups across these categories: AI/Machine Learning, Biotech/Healthtech, Blockchain, Fintech, Mobility, Privacy/Security, Retail/E-commerce, Robotics/IoT/Hardware, SaaS and Social Impact & Education.

TechCrunch is a leading technology media property, dedicated to obsessively profiling startups, reviewing new Internet products, and breaking tech news.

Continue Reading
Advertisement
9 Comments

9 Comments

  1. Abhishek Rao Chimbili

    October 27, 2019 at 4:51 pm

    That is the most useless thing I’ve ever seen.

  2. Brandon S.

    October 27, 2019 at 4:52 pm

    You are supposed to use a spacer. The inhaler alone is not good. Not to mention there are some inhalers that already track the number of uses. This is pointless.

  3. Greg Nulik

    October 27, 2019 at 7:21 pm

    Hope the sensor supports a full dosage.

  4. polyannamoonbeam

    October 27, 2019 at 10:39 pm

    Not enough info …sensor tells you what your trigger was…? How? Blood prick analysis? Heartrate? Allergen analysis? Doctors are now instructed to ration patients to one Ventolin a month, two if you argue at length. There is no science to back up patients self diagnosed need for more, doctors differ on what is sufficient, how to measure severity and are often punitive/ biased against smokers. Many patients become resistant to their Ventolyn due to misuse, long term use.. tracking usage doesnt tell you whether patient needed to use more or less puffs for each event or just misused due to poor technique….severe attacks are not managed by Ventolin. Steroids,adrenalin, intravenous meds, full mask vaporised meds- we use all in winter for son.

  5. Pinitrius

    October 27, 2019 at 11:34 pm

    Being an allergist I was interested to see what this was about… But no! It gives some information about patient adherence to the treatment but as with many products/service it is trying to force a subscription down patients throat without providing real long term value! And the product itself is rendered useless after 12 months due to the non-removable battery!

    To me it is just a gimmick the way they chose to make it and charge for it! Sorry…

  6. TechPimp

    October 28, 2019 at 1:51 am

    I didn’t understand what the heck it does?

  7. Gezaei Teklay

    October 28, 2019 at 2:09 am

    I hope it is helpful for asthma

  8. Arthur

    October 28, 2019 at 9:12 am

    So it counts how many times you use an inhaler a day and displays it on an app?

  9. takeonparis

    October 29, 2019 at 12:15 am

    This is the dumbest interview I’ve ever seen. He doesn’t even bother to ask: “So what does your product DO?” Like what in the actual hell…

Leave a Reply

Cancel reply

Your email address will not be published. Required fields are marked *

Science & Technology

Why Taskrabbit’s Founder Prioritizes Diversity Early │ Build Mode Podcast

As a founder or any team builder, diversity is best built at the start. As Taskrabbit founder Leah Solivan learned, procrastination leads to weaker teams and a harder effort later. We dive into all of her expert tips for builders and founders in the latest episode of our podcast Build Mode right here:

Published

on

As a founder or any team builder, diversity is best built at the start. As Taskrabbit founder Leah Solivan learned, procrastination leads to weaker teams and a harder effort later.

We dive into all of her expert tips for builders and founders in the latest episode of our podcast Build Mode right here:

Continue Reading

Science & Technology

Are orbital data centers all hype, or an actual AI infrastructure solution? l Equity Podcast

Tech companies are racing to build data centers in space, pitching orbital compute as the next frontier for AI infrastructure, even as the technical and economic realities remain far from clear. Add in OpenAI’s massive $122 billion round and Bluesky’s latest AI backlash, and the message is clear: The future of AI is being shaped…

Published

on

Tech companies are racing to build data centers in space, pitching orbital compute as the next frontier for AI infrastructure, even as the technical and economic realities remain far from clear. Add in OpenAI’s massive $122 billion round and Bluesky’s latest AI backlash, and the message is clear: The future of AI is being shaped as much by ambition and hype as it is by real-world constraints.

On this episode of TechCrunch’s Equity podcast, Kirsten Korosec, Anthony Ha, and Sean O’Kane unpack these massive capital bets, user backlash, and off-world compute plans along with Whoop’s major valuation and the literal downfall of robot Olaf.

Subscribe to Equity on YouTube, Apple Podcasts, Overcast, Spotify, and all the casts. You also can follow Equity on X and Threads, at @EquityPod.

Chapters:
00:00 Intro
00:20 A humanoid Olaf robot collapses at Disneyland Paris
03:30 OpenAI raises $122B at an $852B valuation
11:30 Whoop lands $575M and bets big on wearable data
18:50 The risks (and value) of personal health data
23:00 Bluesky’s AI feed builder sparks backlash
30:00 Can Bluesky keep growing — and compete with X?
36:30 The race to build data centers in space
44:30 SpaceX, Starlink, and the business of orbital compute
49:30 Outro

Continue Reading

Science & Technology

When it Comes to Pitching, Don’t be Nice, Just Slay │ Build Mode Podcast

For women entering the founding and startup ecosystem, Taskrabbit founder Leah Solivan has a wealth of insights, especially on why you shouldn’t hold yourself back. Listen in on the latest episode of Build Mode for our full interview with her:

Published

on

For women entering the founding and startup ecosystem, Taskrabbit founder Leah Solivan has a wealth of insights, especially on why you shouldn’t hold yourself back.

Listen in on the latest episode of Build Mode for our full interview with her:

Continue Reading

Trending